Toe Story 2
Today I saw my nurse practitioner at the Joslin Diabetes Center for a regular appointment. We discussed, among the usual matters, foot care for…
Diapep277 and Me
When I was first diagnosed with type 1 diabetes, I was asked to participate in a clinical study for a diabetes “vaccine” called Diapep277. …
Toe Story
Eli, my 18 year old son, sat at the kitchen table and paged through the local newspaper as he ate his breakfast. “Mom, what are diabetic shoes?”…
Tales of Ridicule–From Me Not “Them”
Who among us hasn’t been the brunt of sugar-related jokes?  I was at a dinner for work, for instance, and started talking about how excited…
Summer Reading: Jessica Apple Recommends…
Are you looking for a good book to take along on your vacation this summer? All summer ASweetLife’s bloggers and contributors will be sharing some of their favorites. Can you think of line that's better than the title of this book for a doctor to tell someone as she's being diagnosed with diabetes?
Two New Personal Records
I broke two personal records yesterday – my half marathon record and my blood sugar record (since diagnosis) and both are big disappointments to…
Wild Salmon with Basil Aioli and Quinoa
When we came across this incredible recipe for wild salmon with basil aioli and quinoa, we had to get in touch with Marla Meridith of Family Fresh Cooking and ask for permission to share it. We're delighted she agreed. Thank you, Marla!
Lilly’s New Type 2 Diabetes Drug Receives EU Approval
The new type 2 diabetes drug Trajenta (linagliptin 5 mg film-coated tablets) received Marketing Authorization from the European Commission for the treatment of type 2 diabetes. The European Commission has approved linagliptin in combination with metformin and metformin plus sulfonylurea. Linagliptin is also approved for use as monotherapy in patients...